Cibc Asset Management Inc Acadia Pharmaceuticals Inc Transaction History

Cibc Asset Management Inc

  • $28.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$25.02 - $54.99 $136,208 - $299,365
-5,444 Closed
0 $0
Q3 2020

Nov 05, 2020
BUY
$36.42 - $57.0 $4,916 - $7,695
135 Added 2.54%
5,444 $225,000
Q4 2019

Feb 14, 2020
BUY
$36.21 - $51.4 $192,238 - $272,882
5,309 New
5,309 $227,000

Others Institutions Holding ACAD

# of Institutions
280
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.65B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email